|
Provides a close-up look at Genentech's new cancer drug, Herceptin, a nontoxic therapy that deactivates the protein that makes breast cells turn malignant, and offers a detailed account of its creation, development, and promise as an effective treatment. 60,000 first printing. Tour. Additional Details
\N
BOOK TYPE : NF
BRAND : Bazell, Robert
DEWEY CLASSIFICATION : 616
LANGUAGE : ENGLISH
NUMBER OF PAGES : 240
PUBLISHER IMPRINT CODE : RANPP
PUBLISHER NAME : RANDOM HOUSE INC
RETURNS ACCEPTED? : YES
|